One former New York Giants staffer is adamant that team legend Eli Manning should not be involved in their current ...

Eli Lilly, the maker of blockbuster weight loss and diabetes drugs Zepbound and Mounjaro, said it will invest an additional ...

Eli Lilly launched an ad campaign on Friday, cautioning patients against the risks of unapproved weight-loss drugs in its ...

Pharmaceutical giant expects the move will create 3,000 high-skilled jobs and provide work for approximately 10,000 ...

Eli’s Cheesecake and the Girl Scouts of Greater Chicago and Northwest Indiana are teaming up on St. Patrick’s Day treat made with the popular cookies. The limited-edition treats, available while ...

By Nqobile Dludla JOHANNESBURG (Reuters) -Aspen Pharmacare posted a 5% rise in half-year earnings on Monday and said it ...

Eli Lilly announced plans for four new pharmaceutical manufacturing sites to produce domestic medicine production in the ...

Know any teenagers who’ve got the writing bug? On April 18, Arkansas Tech University in Russellville is hosting its ...

Eli Lilly is seeking to further cement its stance as a leader in weight loss drugs in an ad campaign calling out “unapproved” medications.

Eli Lilly has launched new 7.5 mg and 10 mg single-dose vials of Zepbound (tirzepatide), priced at $499 per month under the ...

Some of the 2025 trends that are sticking around from previous years are the use of curves in furniture, color drenching ...